| 注册
首页|期刊导航|中国肿瘤生物治疗杂志|表达PD-1 shRNA增强靶向CD19 CAR-T细胞对肿瘤细胞的杀伤能力

表达PD-1 shRNA增强靶向CD19 CAR-T细胞对肿瘤细胞的杀伤能力

林伟 朱晶晶 刘秀盈 王建勋

中国肿瘤生物治疗杂志2024,Vol.31Issue(7):655-661,7.
中国肿瘤生物治疗杂志2024,Vol.31Issue(7):655-661,7.DOI:10.3872/j.issn.1007-385x.2024.07.002

表达PD-1 shRNA增强靶向CD19 CAR-T细胞对肿瘤细胞的杀伤能力

Expression of PD-1 shRNA enhances the killing ability of CD19-targeting CAR-T cells on tumor cells

林伟 1朱晶晶 1刘秀盈 1王建勋1

作者信息

  • 1. 北京中医药大学 生命科学学院,北京 102400
  • 折叠

摘要

Abstract

Objective:To design and construct CD19-targeting CAR-T cells expressing PD-1 shRNA and validate their anti-tumor function in vitro.Methods:The authors designed and constructed CD19 CAR molecule gene expressing PD-1 shRNA,and packaged them into retroviral vector using packaging cells.The viral vector copy number was detected by qPCR,and then human primary T cells were transduced to obtain CAR-T cells,which were divided into three groups:RNAU6-CD19 CAR-T,PD-1 shRNA1-CD19 CAR-T,and PD-1 shRNA2-CD19 CAR-T cells.qPCR was applied to detect the expression levels of PD-1 mRNA in three groups of CAR-T cells.Flow cytometry was used to detect the expression level of PD-1 on CAR-T cells in three groups.The luciferase reporter gene method and flow cytometry were used to detect the killing function of CAR-T cells against target cells(human lymphoma daudi cells)at different efficacy to target ratios.Results:Three groups of CAR molecules,namely RNAU6-CD19 CAR,PD-1 shRNA1-CD19 CAR and PD-1 shRNA2-CD19 CAR,were successfully packaged into retroviral vector,in which all retroviral vector copy numbers were higher than 1×107 copies/mL.CAR-T cells were obtained by transducing human primary T cells.The CAR-T transduction efficiencies of RNAU6-CD19 CAR-T,PD-1 shRNA1-CD19 CAR-T and PD-1 shRNA2-CD19 CAR-T cells were 43.1%,55.1%,and 41.7%respectively.Compared with RNAU6-CD19 CAR-T cells,PD-1 shRNA1-CD19 CAR-T and PD-1 shRNA2-CD19 CAR-T cells showed a significant decrease in the expression level of PD-1 mRNA(all P<0.01),lower expression level of PD-1 on cell surface s(all P<0.01),and higher killing efficiency against CD19 positive target cells(daudi cells)in vitro(P<0.05 or P<0.01).Conclusion:Successfull construction of CD19-targeting CAR-T cells expressing PD-1 shRNA can improve the killing efficiency against CD19 positive target cells,reduce the expressions of PD-1 mRNA and its translation product PD-1,and slow down the depletion of CAR-T cells.

关键词

CD19/PD-1/嵌合抗原受体/T细胞/RNA干扰

Key words

CD19/PD-1/chimeric antigen receptor/T cell/RNA interference

分类

医药卫生

引用本文复制引用

林伟,朱晶晶,刘秀盈,王建勋..表达PD-1 shRNA增强靶向CD19 CAR-T细胞对肿瘤细胞的杀伤能力[J].中国肿瘤生物治疗杂志,2024,31(7):655-661,7.

基金项目

北京市双一流高层次人才科研启动经费(No.9011451310032) (No.9011451310032)

中国肿瘤生物治疗杂志

OA北大核心CSTPCD

1007-385X

访问量0
|
下载量0
段落导航相关论文